Clinical application

Inflammation & Infection Pain

After Surgery Orthopedic Surgery

Chronic Trauma Nerve Compression Syndrome

Diabetic Foot and Ulcer Swelling

Sprain Muscle Soreness

Rheumatology Peripheral neuropathy

Foot Vasculopathy and Neuropathy

Diabetic Market and commercial opportunity

5 facts on diabetes

-About 347 million people worldwide have diabetes. And 10% of diabetic patients will have diabetes complication, especially diabetes neuropathy and vascular disease (Diabetic foot disease).

-Diabetes is predicted to become the seventh leading cause of death in the world by the year 2030.

-Cardiovascular disease is responsible for between 50% and 80% of deaths in people with diabetes.

-Diabetes is a leading cause of blindness, amputation and kidney failure.

-Diabetic foot disease, due to changes in blood vessels and nerves, often leads to ulceration and subsequent limb amputation. It is one of the most costly complications of diabetes, especially in communities with inadequate footwear. It results from both vascular and neurological disease processes. Regular inspection and good care of the foot can prevent amputations. Comprehensive foot programs can reduce amputation rates by 45-85%.

So the Diabetic Market is very big.

Our near infrared therapy system could therapy diabetic foot disease and prevent amputations. It is a big commercial opportunity

Advantage

1.Our safety design could protect patients and avoid medical disputes.

1)Adjustment of time:10min,20min,30min.40min,never more than 40minutes

2)Adjustment of energy: Mild,Strong,Moderate

3)Temperature: never more than 41°C

4)The pad, with 66 diodes, could give off near-infrared between 850nm-950nm.

5)The design of diodes sag in rectangular groove could protect patients form burning,which also easy to clean with alcohol wipe.

2.We have passed such international authority certification,such as CE,ISO13485, Production Certificate,Utility Model Patent Certificate and Product Safety Authentication, etc.

3.Our products material are environmentally friendly and safety.

4.We are concentrate on diabetes field and the leader of this filed in China.We could not only provide the therapy equipment to the patients,but also could provide the solution project to them.And help them alleviate suffering and save lives.

Background of Product Development

1.In 1998, Three American scientists, which are Robert F.Furchgott, Louis J.Ignarro, and Ferid Murad found that the NO in human body is the best mediator for blood vessel dilation, and this discovery won the Nobel Prize in Physiology or Medicine.

2.HW-1000,HW-2000 and HW-3000 are developed on basis of this discovery.

3.This device is a safe, noninvasive and drug-free therapy medical instrument.

Treatment principle

1.Super luminous light-emitting diodes in the therapy pads giving off infrared rays, which lights at a wavelength of 850-950nm, could be applied to skin directly.
2.The infrared rays absorbed by body cells could promote angiectasis and improve local blood circulation.
3.Improvement of blood circulation can accelerate wound healing, relieve pain and has good effect on peripheral neuropathy.

4..Monochromatic infrared ray with wavelength of 850-950nm can penetrate 5cm to hypoderm, be absorbed by the endothelial cells that line the inner surface and make NO release locally.
5.Moreover, NO is very good at removing swells, reducing inflammation, accelerating the concrescence of the wounds and promoting bone formation.

Patent No. 201120051319.9

About Company

Beijing Huatai Healthcare Technology Co., Ltd. located in Haidian District, Beijing high-tech business park,is a high-tech enterprise and mainly engaged in research and producing medical instruments.
All the products are manufactured according to related international standards and have received universal approbation both at home and abroad. The products are already exported to Europe, America, Middle East, Africa, etc., and received widespread reputation in these countries and regions.